CS Paper Radar

Reinforcement Learning based control of Cancer Chemotherapy treatments

Jayakody Kankanamalage Chamani Shiranthika

cs.AI cs.LG ·submitted 2026-11-06 16:31 UTC · v1

Abstract

Reinforcement Learning has achieved tremendous success in recent years. Extending its scope from the traditional complex games such as Atari, Go, Pokeman, and Chess, reinforcement learning has caught researchers' attention on modelling real-life scenarios. Personalized medicine and the dynamic treatment regimen are two such preliminary research fields; researchers are focusing their mindsets currently. Estimating the optimal dynamic treatment regimens from the observational real clinical data is being popularized among the researchers, widening its scope towards more advanced versions of reinforcement learning algorithms. This research is about a research study that focused on reinforcement learning techniques that have been approached in the context of cancer chemotherapy treatments. Primarily this thesis addresses the result of the study by means of the state-of-the-art on reinforcement learning techniques used in generating the optimal policy for sequential treatments, including the existing online reinforcement learning approaches. Thereby a simulation for cancer chemotherapy via traditional Q-learning would be presented. Secondly, the study will extend towards using offline reinforcement learning in the optimal policy generation. Thus, the proposed solution follows a data-driven approach, which works on the real human colon cancer clinical data. The novelty of the proposed solution resides in the implementation of an offline reinforcement learning approach by means of a model-based architecture using the conservative Q-learning and the model-based offline policy optimization algorithm. As per the experimental results and the evaluations, it was revealed that the proposed Chemo RL model caters well the problem of cancer chemotherapy treatment scheduling and serves as a supportive model for the junior oncologists in deciding their treatment decisions.

Comment
Masters thesis at the National Taipei University. Received the IEEE Taipei Section, Best Masters thesis award in 2021

Closest papers

Nearest neighbours by meaning across the whole index.

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

cs.LG eess.SY ·2026-09-10 ·Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang
publishedbenchmark similarity 0.73
Abstract · 6 pages. Published in the 2026 American Control Conference (ACC)

Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks.

0.33

Reinforcement Learning In Partially Verifiable Environments for Colon Cancer Treatment Planning

cs.LG cs.AI ·2026-10-12 ·Li-Ching Chen, Andrés Franco Valiente, Yuta Ishiyama, Zachary R. Chalmers, William Chen +5 more
similarity 0.66
Abstract

Clinical decision-making is a sequential process of information collection, clinical inference, and forecasting under partial observability, often without a uniquely correct treatment decision. Large language models (LLMs) have demonstrated strong medical question-answering capabilities but extending these advances to clinical reasoning remains challenging because many clinical tasks are only partially verifiable. Recent clinical reinforcement learning (RL) work has therefore largely focused on diagnostic endpoints, where correctness can be more directly verified. Oncology treatment decision making is a particularly challenging instance of this problem that extends beyond medical question-answering in which multiple decision trajectories can be clinically defensible for the same partially observed patient state. We formulate oncology treatment planning as an interactive RL problem under partial observability and construct patient-specific, process-aware rewards from decision processes observed in real world clinical records. The agent must learn to sequentially acquire information from a structured patient representation before committing to a first-line treatment recommendation, and is evaluated on information gathering, treatment selection, and reasoning alignment. Using GRPO and GDPO to optimize Llama-3.1-8B-Instruct within this environment, RL substantially improves the base policy beyond frontier model capabilities. The GDPO-trained policy increases Mean@3 scalar clinical reward by $79.60\%$ over base Llama and exceeds GPT-5.2 by $18.82\%$ under the same interactive environment, while reducing query count during training. Overall, our results show that patient-specific, partially verifiable rewards can provide an effective learning signal for interactive clinical RL when both the patient state and the underlying clinical decision process are only partially observed.

0.18

Robust Reinforcement Learning for Dynamic Treatment Regimes under Model and Measurement Uncertainty

cs.LG ·2026-10-15 ·Chengze Xie, Xuan Wang, Ying Ding, Hairong Wang, Yan Li
similarity 0.66
Abstract

We develop a robust reinforcement learning (RL) framework for learning adaptive treatment policies that generalize across patients and remain reliable under errors in the measured biomarker and shifts in the disease dynamics. By modeling the patient as a hidden context, we address generalization and robustness in a unified manner through robust contextual Markov decision processes. Applying our framework to adaptive therapy for metastatic prostate cancer in a simulator calibrated to clinical data, we obtain generalizable and robust policies that substantially outperform the existing adaptive therapy method. In particular, we attain robustness with almost no loss of performance when the biomarker is accurate and the disease evolves as anticipated, and find that the resulting policy Pareto-dominates the existing method across a diverse array of scenarios. Our findings suggest that robust RL holds great promise as a principled methodology for learning reliable adaptive treatment policies.

0.17

Behavioral Cloning Outperforms Entropy-Regularized RL: Critic-Driven Failure of Actor-Critic Methods on Adaptive Tumor Treatment

cs.LG ·2026-09-06 ·Aleksandar Dimitrov, Giacomo Spigler
similarity 0.63
Abstract · 9 pages, 3 figures

Adaptive dosing requires policies that reduce tumor burden without excessive toxicity. Learned dosing policies are typically judged against historical or heuristic comparators, which cannot show whether a policy has found the best behavior available. We instead study a three-population tumor-control ODE in which optimal-control analysis fixes the form of a good schedule -- bang-bang dosing punctuated by a singular arc -- and construct a numerical controller of that form as a proxy for near-optimal behavior. Judged against this reference under a sustained-cure criterion -- 200 consecutive days below 5% carrying capacity -- Soft Actor-Critic (SAC) trained from scratch never reaches cure. Behavioral cloning (BC) of the reference reproduces it (100% sustained cure, 30/30 seeds), but SAC fine-tuning of the cloned policy destroys it across five entropy coefficients, and TD3 and BC-regularized SAC fail identically; the pattern persists under multiplicative pharmacokinetic action noise. Along curative trajectories the post-collapse critic ranks the collapsed-policy action above the reference action in 96% of states, concentrated in the maintenance phase, and the policy settles into a non-curative adaptive-therapy equilibrium. The reference is what makes this legible: against a heuristic comparator the fine-tuned policy would read as a competent controller rather than a failure.

0.29

Safe Learning of Adaptive Control Policies for Remote Patient Monitoring

eess.SY ·2026-10-07 ·Ramanan Tamizholi, Siddharth Chandak, Isha Thapa, Nicholas Bambos, David Scheinker
published similarity 0.63
Abstract · Accepted at IEEE Healthcom 2026

Remote Patient Monitoring (RPM) enables continuous observation of patients in their daily environments, improving both health outcomes and quality of life. A key challenge in RPM is determining the optimal monitoring intensity, while balancing patient safety and monitoring costs. This problem is further complicated when system parameters, such as transition probabilities and costs, are initially unknown. We develop a learning-based control framework that estimates these parameters and adapts the monitoring policy in real time. The proposed approach is an online model-based reinforcement learning algorithm tailored to RPM, with patient safety explicitly prioritized during exploration. We provide theoretical guarantees on safety and convergence to the optimal policy. Simulation results show that the algorithm converges to the optimal threshold-based policy, maintains low treatment costs, and reduces the risk of patients reaching critical health states.

0.42

Learning to Play: Reinforcement Learning and Games

cs.AI ·2026-10-12 ·Aske Plaat
highly cited similarity 0.61
Abstract · 342 pages, textbook

Amazing breakthroughs in reinforcement learning have taken place. Computers teach themselves to play Chess and Go and beat world champions. There is talk about expanding application areas towards general artificial intelligence (AI). The breakthroughs in Backgammon, Checkers, Chess, Atari, Go, Poker, and StarCraft have shown that we can build machines that exhibit intelligent game playing of the highest level. These successes have been widely publicized in the media, and inspire AI entrepreneurs and scientists alike. Reinforcement learning in games has become a mainstream AI research topic. It is a broad topic, and the successes build on a range of diverse techniques, from exact planning algorithms, to adaptive sampling, deep function approximation, and ingenious self-play methods. Perhaps because of the breadth of these technologies, or because of the recency of the breakthroughs, there are few books that explain these methods in depth. This book covers all methods in one comprehensive volume, explaining the latest research, bringing you as close as possible to working implementations, with many references to the original research papers. The programming examples in this book are in Python, the language in which most current reinforcement learning research is conducted. We help you to get started with machine learning frameworks such as Gym, TensorFlow, and Keras, and provide exercises to help understand how AI is learning to play.

0.40

The Evidence Ladder for Reinforcement Learning in Healthcare: From Retrospective Policies to Trusted Interventions

cs.LG ·2026-09-20 ·Yunfan Zhao
similarity 0.60
Abstract

Reinforcement learning (RL) offers a natural language for healthcare decisions whose conse- quences unfold over time, yet most reported progress remains far from routine intervention. Ex- isting surveys organize the field by algorithm or clinical application. We instead review healthcare RL through an evidence ladder: problem formulation, retrospective identification, policy estima- tion, stress testing, prospective evaluation, and lifecycle monitoring. This view connects clinical treatment, patient engagement, and health-system operations while exposing a recurring gap: evi- dence that a policy scores well in a historical dataset is not evidence that it will improve care. We synthesize the assumptions and failure modes at each rung, identify what evidence can and can- not transfer across settings, and propose reporting practices for cumulative evaluation. Restless bandits are included as one special case, not as the organizing framework. The central lesson is that healthcare RL should be evaluated as an intervention embedded in a changing sociotechnical system, rather than only as an optimizer of a retrospective reward.

0.22

Simulation-aided Reinforcement Learning with Control Variates

cs.LG cs.RO ·2026-11-09 ·Omer Hemo, Ido Sefi, Mirco Mutti, Aviv Tamar, Kfir Y. Levy
publishedbenchmarkcode/data similarity 0.60
Abstract · Accepted as a poster at NeurIPS 2026. 10 pages main text + appendix, 3 figures. Code: https://github.com/OmerHemo/Simulation-Aided-Reinforce…

Reinforcement Learning (RL) algorithms often rely on data collected from a target environment, which can be expensive and noisy. Although simulators can generate large amounts of additional data, standard simulation mixing approaches, which directly combine simulated and real experience, can degrade performance due to simulator inaccuracies, especially when they bias the solution away from the optimal policy. We propose a conservative simulation-aided learning method based on control variates, where simulated data is used solely to reduce variance in the learning process rather than directly shaping the learning target. We develop our approach for Policy-Evaluation, which is a fundamental building block of RL algorithms. Then we combine it within the actor-critic framework towards policy improvement, as well as extend it towards offline RL scenarios. Experiments on multiple MuJoCo benchmark tasks demonstrate improvements over standard simulation mixing approaches, highlighting control variates as an effective tool for simulation-aided reinforcement learning.

0.36